116 related articles for article (PubMed ID: 36993760)
1. Serial SARS-CoV-2 antibody titers in vaccinated dialysis patients: prevalence of unrecognized infection and duration of seroresponse.
Hsu CM; Weiner DE; Manley HJ; Miskulin D; Ladik V; Frament J; Argyropoulos C; Abreo K; Chin A; Gladish R; Salman L; Johnson D; Lacson EK
medRxiv; 2023 Mar; ():. PubMed ID: 36993760
[TBL] [Abstract][Full Text] [Related]
2. Serial SARS-CoV-2 Antibody Titers in Vaccinated Dialysis Patients: Prevalence of Unrecognized Infection and Duration of Seroresponse.
Hsu CM; Weiner DE; Manley HJ; Li NC; Miskulin D; Harford A; Sanders R; Ladik V; Frament J; Argyropoulos C; Abreo K; Chin A; Gladish R; Salman L; Johnson D; Lacson EK
Kidney Med; 2023 Nov; 5(11):100718. PubMed ID: 37786901
[TBL] [Abstract][Full Text] [Related]
3. Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months.
Hsu CM; Weiner DE; Manley HJ; Aweh GN; Ladik V; Frament J; Miskulin D; Argyropoulos C; Abreo K; Chin A; Gladish R; Salman L; Johnson D; Lacson EK
Clin J Am Soc Nephrol; 2022 Mar; 17(3):403-413. PubMed ID: 35144972
[TBL] [Abstract][Full Text] [Related]
4. Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study.
Vinh DC; Gouin JP; Cruz-Santiago D; Canac-Marquis M; Bernier S; Bobeuf F; Sengupta A; Brassard JP; Guerra A; Dziarmaga R; Perez A; Sun Y; Li Y; Roussel L; Langelier MJ; Ke D; Arnold C; Whelan M; Pelchat M; Langlois MA; Zhang X; Mazer BD;
Lancet Healthy Longev; 2022 Mar; 3(3):e166-e175. PubMed ID: 35224524
[TBL] [Abstract][Full Text] [Related]
5. Quantitative Analysis of SARS-CoV-2 Antibody Levels in Cancer Patients Post Three Doses of Immunization and Prior to Breakthrough COVID-19 Infections.
Macrae K; Martinez-Cajas J; Bessai K; Abdulhamed A; Gong Y
Curr Oncol; 2022 Sep; 29(10):7059-7071. PubMed ID: 36290831
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Vaccine Effectiveness and Breakthrough Infections Among Patients Receiving Maintenance Dialysis.
Manley HJ; Li NC; Aweh GN; Hsu CM; Weiner DE; Miskulin D; Harford AM; Johnson D; Lacson E
Am J Kidney Dis; 2023 Apr; 81(4):406-415. PubMed ID: 36462570
[TBL] [Abstract][Full Text] [Related]
7. Evolution of anti-SARS-CoV-2 spike protein titers after two-dose of COVID-19 vaccination among people living with HIV.
Liu WD; Pang MW; Wang JT; Sun HY; Huang YS; Lin KY; Wu UI; Li GC; Liu WC; Su YC; He PC; Lin CY; Yeh CY; Cheng YC; Yao Y; Chen YT; Wu PY; Chen LY; Luo YZ; Chang HY; Sheng WH; Hsieh SM; Chang SY; Hung CC; Chang SC
J Virus Erad; 2022 Dec; 8(4):100308. PubMed ID: 36531082
[TBL] [Abstract][Full Text] [Related]
8. Immune Responses after a Third Dose of mRNA Vaccine Differ in Virus-Naive versus SARS-CoV-2- Recovered Dialysis Patients.
Attias P; Azzaoui I; El Karoui K; de La Selle A; Sokal A; Chappert P; Grimbert P; Fernandez I; Bouvier M; Samson C; Dahmane D; Rieu P; Nizard P; Fourati S; Sakhi H; Mahévas M;
Clin J Am Soc Nephrol; 2022 Jul; 17(7):1008-1016. PubMed ID: 35764393
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Dynamic Humoral Response to SARS-CoV-2 mRNA Vaccines in Patients on Peritoneal Dialysis.
Quiroga B; Soler MJ; Ortiz A; Gansevoort RT; Leyva A; Rojas J; de Sequera P;
Vaccines (Basel); 2022 Oct; 10(10):. PubMed ID: 36298603
[TBL] [Abstract][Full Text] [Related]
10. [Antibody Response After Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthcare Workers with and without Previous COVID-19 Infection: A Prospective Observational Study].
Özgür D; Tütüncü EE
Mikrobiyol Bul; 2022 Jan; 56(1):36-48. PubMed ID: 35088958
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 Antibody Response After a Third Dose of the BNT162b2 Vaccine in Patients Receiving Maintenance Hemodialysis or Peritoneal Dialysis.
Bensouna I; Caudwell V; Kubab S; Acquaviva S; Pardon A; Vittoz N; Bozman DF; Hanafi L; Faucon AL; Housset P
Am J Kidney Dis; 2022 Feb; 79(2):185-192.e1. PubMed ID: 34508833
[TBL] [Abstract][Full Text] [Related]
12. Influencing factors of anti-SARS-CoV-2-spike-IgG antibody titers in healthcare workers: A cross-section study.
Reusch J; Wagenhäuser I; Gabel A; Eggestein A; Höhn A; Lâm TT; Frey A; Schubert-Unkmeir A; Dölken L; Frantz S; Kurzai O; Vogel U; Krone M; Petri N
J Med Virol; 2023 Jan; 95(1):e28300. PubMed ID: 36369641
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity after two and three doses of mRNA vaccine in patients with cancer treated with exclusive radiotherapy.
Scoccianti S; Delli Paoli C; Infantino M; Paoletti L; Caini S; Meacci F; Russo S; Esposito M; Fondelli S; Grilli Leonulli B; Grossi V; Barca R; Alpi P; Furlan F; Perna M; Pino MS; Martella F; Manfredi M; Stefanacci M; Bassetti A; Casprini P; Fioretto L
Int Immunopharmacol; 2023 Sep; 122():110460. PubMed ID: 37392566
[TBL] [Abstract][Full Text] [Related]
14. Differences in SARS-CoV-2-Specific Antibody Responses After the First, Second, and Third Doses of BNT162b2 in Naïve and Previously Infected Individuals: A 1-Year Observational Study in Healthcare Professionals.
Ogrič M; Žigon P; Podovšovnik E; Lakota K; Sodin-Semrl S; Rotar Ž; Čučnik S
Front Immunol; 2022; 13():876533. PubMed ID: 35711413
[TBL] [Abstract][Full Text] [Related]
15. A prospective observational study for justification, safety, and efficacy of a third dose of mRNA vaccine in patients receiving maintenance hemodialysis.
Espi M; Charmetant X; Barba T; Mathieu C; Pelletier C; Koppe L; Chalencon E; Kalbacher E; Mathias V; Ovize A; Cart-Tanneur E; Bouz C; Pellegrina L; Morelon E; Juillard L; Fouque D; Couchoud C; Thaunat O;
Kidney Int; 2022 Feb; 101(2):390-402. PubMed ID: 34856313
[TBL] [Abstract][Full Text] [Related]
16. Quantitative Analysis of SARS-CoV-2 Serological Responses Post Three Doses of Immunization and Prior to Breakthrough COVID-19 Infections.
Macrae K; Gong CY; Sheth P; Martinez-Cajas J; Gong Y
Vaccines (Basel); 2022 Sep; 10(10):. PubMed ID: 36298455
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 spike protein antibody titers 6 months after SARS-CoV-2 mRNA vaccination among patients undergoing hemodialysis in Japan.
Kanai D; Wakui H; Haze T; Azushima K; Kinguchi S; Tsukamoto S; Kanaoka T; Urate S; Toya Y; Hirawa N; Kato H; Watanabe F; Hanaoka K; Hanaoka M; Mitsuhashi H; Yamaguchi S; Ohnishi T; Tamura K
Clin Exp Nephrol; 2022 Oct; 26(10):988-996. PubMed ID: 35751753
[TBL] [Abstract][Full Text] [Related]
18. Humoral and Cellular Immune Response After a 3-Dose Heterologous SARS-CoV-2 Vaccination Using the mRNA-BNT162b2 and Viral Vector Ad26COVS1 Vaccine in Hemodialysis Patients.
Davidovic T; Schimpf J; Abbassi-Nik A; Stockinger R; Sprenger-Mähr H; Lhotta K; Zitt E
Front Immunol; 2022; 13():907615. PubMed ID: 35812459
[TBL] [Abstract][Full Text] [Related]
19. The persistence of anti-Spike antibodies following two SARS-CoV-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controls-a prospective cohort study.
Christensen IE; Jyssum I; Tveter AT; Sexton J; Tran TT; Mjaaland S; Kro GB; Kvien TK; Warren DJ; Jahnsen J; Munthe LA; Haavardsholm EA; Vaage JT; Grødeland G; Lund-Johansen F; Jørgensen KK; Syversen SW; Goll GL; Provan SA
BMC Med; 2022 Oct; 20(1):378. PubMed ID: 36199139
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the SARS-CoV-2 Antibody Response to the BNT162b2 Vaccine in Patients Undergoing Hemodialysis.
Yau K; Abe KT; Naimark D; Oliver MJ; Perl J; Leis JA; Bolotin S; Tran V; Mullin SI; Shadowitz E; Gonzalez A; Sukovic T; Garnham-Takaoka J; de Launay KQ; Takaoka A; Straus SE; McGeer AJ; Chan CT; Colwill K; Gingras AC; Hladunewich MA
JAMA Netw Open; 2021 Sep; 4(9):e2123622. PubMed ID: 34473256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
